GenMont Biotech Incorporation (TPE:3164)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.05
+0.50 (2.85%)
Mar 10, 2026, 1:30 PM CST
-16.44%
Market Cap 1.55B
Revenue (ttm) 391.48M
Net Income (ttm) 34.49M
Shares Out 86.01M
EPS (ttm) 0.39
PE Ratio 46.29
Forward PE n/a
Dividend 0.80 (4.56%)
Ex-Dividend Date Mar 27, 2025
Volume 57,368
Average Volume 72,587
Open 17.70
Previous Close 17.55
Day's Range 17.70 - 18.05
52-Week Range 17.20 - 23.35
Beta 0.20
RSI 36.49
Earnings Date Mar 13, 2026

About TPE:3164

GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan. It offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. The company was founded in 2000 and is based in Tainan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 3164
Full Company Profile

Financial Performance

In 2024, TPE:3164's revenue was 385.37 million, an increase of 21.18% compared to the previous year's 318.02 million. Earnings were 57.25 million, an increase of 73.54%.

Financial Statements

News

There is no news available yet.